C-Rad AB announced consolidated earnings results for the fourth quarter and year ended December 31, 2012. For the quarter, the company’s net sales were SEK 11,384,000 against SEK 3,660,000 a year ago. Operating loss was SEK 1,475,000 against SEK 24,768,000 a year ago. Net loss of the period was SEK 1,462,000 against SEK 24,921,000 a year ago. Cash flow from operating activities was SEK 4,444,000 against SEK 2,062,000 a year ago. Diluted loss per share were SEK 0.02 against diluted loss per share of SEK 1.85 a year ago. Cash flow from operating activities was SEK 993,000 against cash flow used in operating activities of SEK 4,954,000 a year ago. EBITDA was SEK 0.6 million against LBITDA of SEK 4.8 million a year ago. For the year, the company reported net sales were SEK 25,776,000 against SEK 14,910,000 a year ago. Operating loss was SEK 19,050,000 against SEK 42,104,000 a year ago. Net loss of the period was SEK 19,389,000 against SEK 42,607,000 a year ago. Diluted loss per share was SEK 1.11 against SEK 2.51 a year ago. Cash flow used in operating activities was SEK 13,755,000 against SEK 17,024,000 a year ago. LBITDA was SEK 13.6 million against LBITDA of SEK 4.8 million a year ago.

C-RAD AB with its three fully owned subsidiaries in Sweden and three international sales companies are all active in the field of radiation therapy. The University Hospital has ordered as part of their linac procurement two Catalyst and one Sentinel System. The Catalyst™ is a next-generation high performance tracking system based on optical surface scanning and augmented reality through re-projection. Advanced and highly optimized algorithms for non-rigid registration and deformable models enable clinicians to perform a real-time assessment of patient positioning errors before and during treatment delivery. Interfaces to major vendors ensure a completely integrated workflow. The Sentinel TM is a dedicated system for 4DCT studies and motion detection. The hospital will use the Catalyst system for respiratory gating at two Elekta linacs. The Sentinel System upgrades the existing Siemens CT to do prospective and retrospective CT studies.

C-Rad AB announced consolidated earnings results for the third quarter and nine months ended September 30, 2012. For the quarter, net sales were SEK 4,633,000 against 3,365,000 a year ago. Operating loss was SEK 5,132,000 against SEK 3,796,000 a year ago. Net loss of the period was SEK 5,227,000 against SEK 3,942,000 a year ago. Cash flow from operating activities was SEK 4,444,000 against SEK 2,062,000 a year ago. Loss per share after tax was SEK 1.13 against SEK 1.44 a year ago. LBITA were SEK 17.6 million against SEK 17.3 million a year ago. For the nine months, the company reported net sales were SEK 14,392,000 against 11,249,000 a year ago. Operating loss was SEK 17,574,000 against SEK 17,336,000 a year ago. Net loss of the period was SEK 17,927,000 against SEK 17,685,000 a year ago. Cash flow from operating activities was SEK 14,637,000 against SEK 12,069,000 a year ago.